Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

NCT05809583 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding withdrawn

Conditions

Ulcerative Colitis

Interventions

DRUG: Ozanimod

Sponsor

Beth Israel Deaconess Medical Center